US: Mepergan Fortis Capsules; Final Decision on Proposal to Refuse Approval of Supplemental New Drug Application; Availability of Final Decision
US: Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products
US: Medicare Program; CY 2018 Updates to the Quality Payment Program; and Quality Payment Program: Extreme and Uncontrollable Circumstance Policy for the Transition Year
US: Medicare Shared Savings Program Requirements; and Medicare Diabetes Prevention Program for CY 2018
US: Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule
US: Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical
Center Payment Systems and Quality Reporting Programs
US: Unique Device Identification; Direct Marking of Devices
US: Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled
Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine and Phenylpropanolamine for 2017
US: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment
Parameters for 2019
US: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for
Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, and End-Stage Renal
Disease Quality Incentive Program
EU: UPDATE - Guidance published by Member States on the implementation of the Falsified Medicines Directive
Contact us at info@arq-on.com.